We focus on the oncogenic transcription factors TAL1, LMO2, and NOTCH1 and highlight the significance of the transcriptional regulatory programs in normal hematopoietic stem cells and T-ALL. The gene discussed is LMO2; the disease is acute lymphoblastic leukemia.